INTRODUCTION
Soft tissue tumors are defined as mesenchymal proliferations which occur in the extraskeletal nonepithelial tissues of the body, excluding the viscera, coverings of brain and lymphoreticular system. 1 The annual incidence of soft tissue tumor is 1.4 per 100000 population. 1 Soft tissue tumors are the fourth most common malignancy in children, after hematopoietic neoplasm, neural tumor and Wilms tumor. Soft tissue sarcomas account for 15% of all childhood cancers. Benign tumors outnumber malignant ones by margin of 100:1. Systemic clinical study of soft tissue tumors were primarily initiated by Pack and his colleagues. 2 The annual incidence of benign soft tissue tumors is 300 per 100000 and that of sarcoma is 1.4 per 100000 population. 1 Incidence of soft tissue tumors varies depending on age and sex of patient. Soft tissue Sarcoma is more common in men.
Classification of soft tissue tumors: The first classification of soft tissue tumors was given by Rokitansky in 1842. 1 Wilkis in 1859, proposed a classification based on cellular and fibrous components of tumors. 1 Brost in 1902 classified soft tissue tumors based on histogenesis and structure. Stout in 1953 proposed classification of tumors based on histogenesis, morphology and behavior. 2 Classification of soft tissue tumors by Armed Forces Institute of Pathology (AFIP) in 1957, 1967 and 1983 . WHO in 1969 proposed classification of soft tissue tumors based on review of more than 500 soft tissue tumors, which was later on revised in 1994. 2 The classification followed in this study is "Histologic classification of soft tissue tumors" given in Enzinger and Weiss's soft tissue tumor, 4
th Edition, Chapter-1, page No. 7. This classification is similar but not identical to the 1994 WHO classification. 1 Histologic grade represents the most important prognostic factor for all soft tissue sarcomas, strongly associated with the advent of metastasis and patients survival. 3 Multiple studies have confirmed its effectiveness for predicting distant metastases and overall survival, and histologic grade has even shown some value in predicting local recurrence. 4 Grading forms a central and necessary element of the major clinical staging systems for sarcoma and is regarded by most contemporary oncologists as an absolute necessity for clinical decision making. The histological parameters taken into consideration are degree of cellularity, cellular pleomorphism, mitotic activity (frequency and abnormality), degree of necrosis, expansive or infiltrative and invasive growth. Other factors are matrix formation, hemorrhage, calcification and inflammatory infiltrate. 5 In 1982, Markhede et al. 6, 7 suggested a grading system that used four grades based on cellularity, cellular pleomorphism, mitotic activity. Grade-1 and 2 tumors had similar clinical course. 5 and 10 years survival rates with grade 3 tumors were 68% and 55% respectively and with grade 4-tumors they were 47% and 26% respectively.
In 1983, Myhre Jensen et al. 7, 8 graded 261 soft tissue tumors. They employed 3-grades with 5 years survival rates of 97% for grade-1 tumors, 67% for grade-2 and 38% for grade-3 tumors. The histologic parameters used were cellularity, pleomorphism, mitotic rates.
Costa et al. 9 described a grading system based on review of 163 sarcomas from National Cancer Institute (NCI). The histologic parameters used were cellularity, cellular pleomorphism, mitotic rate and necrosis. They employed a 3-grade system, 5 years survival rates were 100%, 73% and 46% respectively.
Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) System: In 1984 Trojani et al., 10, 11 presented FNCLCC system of grading soft tissue sarcoma based on analysis of 155 adult patients. So far FNCLCC system is the best documented and tested system. There are 145 (58%) males and 105 (42%) females in the present study. The male:female ratio = 1.38:1. The most common location of soft tissue sarcomas is lower extremity (77%). It was evenly distributed over trunk, chest, upper axilla. PNET shows uniform, small round to oval cells containing cytoplasmic glycogen and arranged in peritheliomatous pattern. Immunohistochemistry shows positivity for CD99. 1 The youngest patient was 5 months female (Ganglioneuroblastoma).
The most common histological types of sarcomas were MFH (44.4%) & liposarcomas (28.8%) which were in agreement with Enzinger & Weiss. 16, 17 Of the 250 sarcomas studied by FNCLCC grading system, Grade 1 -were 50 cases accounting for 20% of all sarcomas. These patients with well differentiated tumours (Grade 1) showed 96% 5 year survival rate and No metastasis was detected. The P value <0.05 which is statistically significant. Grade 2 -were 75 cases accounting for 30% of all sarcomas. These patients with moderately differentiated tumours (Grade 2) showed 94% 5 year survival rate and 05% cases showed metastatic deposits. The P value <0.05 which is statistically significant. Grade 3 -were 125 cases accounting for 50% of all sarcomas. These patients with poorly differentiated tumours (Grade 3) showed only 04% 5 year survival rate and 045% cases showed metastatic deposits. The P value <0.05 is statistically significant.
The results obtained from FNCLCC grading system of sarcoma were very well correlated with the studies conducted by Rosai & Ackerman & Anderson et al. 18, 19 By the NCI (Costa et al.) grading system Grade 1 -were 70 cases accounting for 28% of all sarcomas. These patients with well differentiated tumours (Grade 1) showed 85% 5 year survival rate and 15% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant. Grade 2 -were 85 cases accounting for 34% of all sarcomas. These patients with moderately differentiated tumours (Grade 2) showed 87% 5 year survival rate and 15% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant. Grade 3 -were 95 cases accounting for 38% of all sarcomas. These patients with poorly differentiated tumours (Grade 3) showed only 07 % 5 year survival rate and 40% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant.
By Myhre Jensen et al. grading system Grade 1 -were 84 cases accounting for 33% of all sarcomas. This patients with well differentiated tumours (Grade 1) showed 59% 5 year survival rate and 35% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant. Grade 2 -were 98 cases accounting for 39% of all sarcomas. These patients with moderately differentiated tumours (Grade 2) showed 75% 5 year survival rate and 25% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant. Grade 3 -were 68 cases accounting for 27% of all sarcomas. These patients with poorly differentiated tumours (Grade 3) showed only 19 % 5 year survival rate and 25% cases showed metastatic deposits. The P value >0.05 which is statistically insignificant.
Guillou et al. 20 found that in univariate analysis, the FNCLCC system was slightly better at predicting tumor mortality and distant metastases. In multivariate analysis, it was more efficient than the NCI system in predicting metastasis in patients with grade 3 tumors and showed better correlation with overall survival. The FNCLCC system also was superior at selecting patients with grade 1 tumors relative to the NCI system. Of note, the necessary microscopic assessment of necrosis in the study by Guillou et al. might have underestimated the extent of necrosis compared with gross assessment and might, therefore, have hampered the performance of the NCI system, in which gross assessment is recommended. Notwithstanding, grading discrepancies were observed in 34.6% of the cases, and both systems had a similar percentage of grade 1 lesions that metastasized. Perhaps most important, the FNCLCC system allocated significantly fewer patients to the intermediate.
In absence of specialized techniques, the updated FNCLCC system for histologic grading seems to be the most effective and has mounting appeal internationally.
20

CONCLUSION
Histologic grade represents the most important prognostic factor for all soft tissue sarcomas. It is the most important factor strongly associated with the advent of metastasis and patients survival. Among the Various Grading systems that were tested for prognostic outcome, FNCLCC grading system is the best documented and tested system. The present study strongly recommends FNCLCC grading system of soft tissue sarcomas to be internationally accepted because the grading system has well defined criteria & so least possible chances of interobserver variability.
The present study & few other previous studies highly recommend the mandatory use of FNCLCC grading systems in histopathology report format.
